168 related articles for article (PubMed ID: 25167079)
1. Effects of dosing protocol on distribution of propranolol in periocular tissues after topical ocular instillation.
Liu H; Yang MB; Li SK; Hao J
Curr Eye Res; 2015 May; 40(6):638-45. PubMed ID: 25167079
[TBL] [Abstract][Full Text] [Related]
2. Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration.
Hao J; Yang MB; Liu H; Li SK
J Ocul Pharmacol Ther; 2011 Oct; 27(5):453-9. PubMed ID: 21810027
[TBL] [Abstract][Full Text] [Related]
3. Periocular Tissue Concentrations of Propranolol after Ocular Instillation of a Gel-Forming Solution.
Yang MB; Liu H; Li SK; Hao J
Curr Drug Deliv; 2016; 13(7):1144-1151. PubMed ID: 26666297
[TBL] [Abstract][Full Text] [Related]
4. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
[TBL] [Abstract][Full Text] [Related]
5. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.
Tajika T; Isowaki A; Sakaki H
J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027
[TBL] [Abstract][Full Text] [Related]
6. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Marey HM; Elmazar HF; Mandour SS; Khairy HA
J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
[TBL] [Abstract][Full Text] [Related]
7. Propranolol and periocular capillary hemangiomas: assessment of refractive effect.
Glasman P; Chandna A; Nayak H; Mangat S; Kaye S
J Pediatr Ophthalmol Strabismus; 2014; 51(3):165-70. PubMed ID: 24877527
[TBL] [Abstract][Full Text] [Related]
8. Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%.
Glogowski S; Lowe E; Siou-Mermet R; Ong T; Richardson M
J Ocul Pharmacol Ther; 2014 Feb; 30(1):66-73. PubMed ID: 24325539
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and local safety profile of propranolol eye drops in rabbits.
Padrini L; Isacchi B; Bilia AR; Pini A; Lanzi C; Masini E; Della Bona ML; Calvani AM; Ceccantini R; la Marca G; Filippi L
Pediatr Res; 2014 Oct; 76(4):378-85. PubMed ID: 25029260
[TBL] [Abstract][Full Text] [Related]
10. Ocular pharmacokinetics profile of different indomethacin topical formulations.
Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
[TBL] [Abstract][Full Text] [Related]
11. Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits.
Lin J; Sun J; Wang Y; Ma Y; Chen W; Zhang Z; Gui G; Lin B
J Ocul Pharmacol Ther; 2015 Feb; 31(1):51-6. PubMed ID: 25229266
[TBL] [Abstract][Full Text] [Related]
12. Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma.
Fabian ID; Ben-Zion I; Samuel C; Spierer A
Am J Ophthalmol; 2011 Jan; 151(1):53-8. PubMed ID: 20970771
[TBL] [Abstract][Full Text] [Related]
13. Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys.
Proksch JW; Lowe ER; Ward KW
Drug Metab Dispos; 2011 Jul; 39(7):1181-7. PubMed ID: 21441467
[TBL] [Abstract][Full Text] [Related]
14. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits.
Iyer GR; Cason MM; Womble SW; Li G; Chastain JE
J Ocul Pharmacol Ther; 2015 May; 31(4):204-10. PubMed ID: 25775192
[TBL] [Abstract][Full Text] [Related]
15. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation.
Ishii K; Matsuo H; Fukaya Y; Tanaka S; Sakaki H; Waki M; Araie M
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1169-77. PubMed ID: 12601046
[TBL] [Abstract][Full Text] [Related]
16. Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina.
Mizuno K; Koide T; Shimada S; Mori J; Sawanobori K; Araie M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2839-47. PubMed ID: 19218605
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Sirolimus Eye Drops Following Topical Ocular Administration in Rabbits.
Lin J; Lu Z; Wang Y; Zhang J; Guo J; Huang Y; Lin B; Yang W
J Ocul Pharmacol Ther; 2023 Dec; 39(10):735-743. PubMed ID: 37579189
[No Abstract] [Full Text] [Related]
18. Oral propranolol in the management of periocular capillary hemangiomas.
Yen KG; Hussein MA
Int Ophthalmol Clin; 2013; 53(3):143-51. PubMed ID: 23751438
[No Abstract] [Full Text] [Related]
19. Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys.
Fukano Y; Kawazu K; Akaishi T; Bezwada P; Pellinen P
J Ocul Pharmacol Ther; 2011 Jun; 27(3):251-9. PubMed ID: 21491995
[TBL] [Abstract][Full Text] [Related]
20. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing.
Tan AY; LeVatte TL; Archibald ML; Tremblay F; Kelly ME; Chauhan BC
J Glaucoma; 2002 Apr; 11(2):134-42. PubMed ID: 11912361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
